Search research articles
Contact Us
Filters
Showing results (401-410 of 422) with videos related to
Page
of 43
Sort By:
Journal of Medicinal Chemistry
|
August 24, 2013
Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma
Brent D G Page, Danielle C Croucher, Zhi Hua Li, et al.
Journal of Internal Medicine
|
July 10, 2019
Current and emerging avenues for Alzheimer's disease drug targets
R Loera-Valencia, A Cedazo-Minguez, P A Kenigsberg, et al.
Journal of the American Chemical Society
|
December 28, 2020
Quaternary Charge-Transfer Complex Enables Photoenzymatic Intermolecular Hydroalkylation of Olefins
Claire G Page, Simon J Cooper, Jacob S DeHovitz, et al.
The Journal of Biological Chemistry
|
December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase
Lisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 1, 2025
A novel, rapidly progressive ataxia due to a spontaneous Myo5a mutation in mice impairs transport proteins and alters mitochondria
Alexander M Telenson, Ryan R Hsieh, Gabrielle J Cowen, et al.
Annals of the Royal College of Surgeons of England
|
February 28, 2015
Female gender and diabetes mellitus increase the risk of recurrence after laparoscopic incisional hernia repair
S T Hornby, F D McDermott, M Coleman, et al.
Metabolites
|
February 25, 2023
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity
Jennifer I Brown, Peng Wang, Alan Y L Wong, et al.
Cancer Chemotherapy and Pharmacology
|
June 30, 2005
Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance
Elizabeth R Glaze, Amy L Lambert, Adaline C Smith, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
Sina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Science Signaling
|
April 24, 2014
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer
Andrea Z Lai, Sean Cory, Hong Zhao, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 422) with videos related to
Sort By:
Page
of 43
Journal of Medicinal Chemistry
|
August 24, 2013
Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma
Brent D G Page, Danielle C Croucher, Zhi Hua Li, et al.
Journal of Internal Medicine
|
July 10, 2019
Current and emerging avenues for Alzheimer's disease drug targets
R Loera-Valencia, A Cedazo-Minguez, P A Kenigsberg, et al.
Journal of the American Chemical Society
|
December 28, 2020
Quaternary Charge-Transfer Complex Enables Photoenzymatic Intermolecular Hydroalkylation of Olefins
Claire G Page, Simon J Cooper, Jacob S DeHovitz, et al.
The Journal of Biological Chemistry
|
December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase
Lisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 1, 2025
A novel, rapidly progressive ataxia due to a spontaneous Myo5a mutation in mice impairs transport proteins and alters mitochondria
Alexander M Telenson, Ryan R Hsieh, Gabrielle J Cowen, et al.
Annals of the Royal College of Surgeons of England
|
February 28, 2015
Female gender and diabetes mellitus increase the risk of recurrence after laparoscopic incisional hernia repair
S T Hornby, F D McDermott, M Coleman, et al.
Metabolites
|
February 25, 2023
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity
Jennifer I Brown, Peng Wang, Alan Y L Wong, et al.
Cancer Chemotherapy and Pharmacology
|
June 30, 2005
Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance
Elizabeth R Glaze, Amy L Lambert, Adaline C Smith, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
Sina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Science Signaling
|
April 24, 2014
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer
Andrea Z Lai, Sean Cory, Hong Zhao, et al.
Page
of 43